Abstract:Disturbed sleep is a common subjective complaint among individuals with anxiety disorders. Sleep deprivation increases general and specific anxiety symptoms among healthy individuals. The amygdala is critical for regulating anxiety and also involved in mediating the effects of emotions on sleep. Neuropeptide S (NPS) and NPS receptors (NPSR) are reported as a novel endogenous arousal and anxiolytic system, but it is unclear yet whether this system is involved in anxiety-like behavior and sleep caused by sleep deprivation, and how it plays anxiolytic effect underlying the comorbid condition. In the present study, we demonstrate that paradoxical sleep deprivation (PSD) induced by modified multiple platform method (MMPM) for 24 h caused anxiety-like behavior, a prolonged sleep latency and subsequent paradoxical sleep (PS) rebound accompanied by an increase in electroencephalogram (EEG) theta (4.5-8.5 Hz) activities across light and dark phase in rats. The increase of PS after PSD was due to an increase of episode number during light phase and both episode number and duration during dark phase. Central action of NPS (1 nmol) attenuated PSD-induced anxiety-like behavior, and altered PSD-induced sleep-wake disturbances through increasing wakefulness, and suppressing PS and EEG theta activities. The reduction in PS time following NPS administration during light phase was because of a decreased episode number. Furthermore, sleep amount in 24 h in PSD rats given NPS was lesser than that given saline. PSD significantly enhanced NPSR mRNA expression level in the amygdala. NPS remarkably increased the number of Fos-ir neurons in the basolateral amygdala (BLA), the central amygdala (CeA) and medial amygdala (MeA). The majority of Fos-ir neurons induced by NPS also expressed NPSR. These results suggest that NPSR upregulation in the amygdala is presumably related to the PSD-induced anxiety-like behavior and sleep disturbances, and that NPS counteracts PSD-induced anxiety-like behavior and sleep disturbances possibly through activating the neurons bearing NPSR in the amygdala. In addition, the little sleep increase in PSD rats treated with NPS suggests that NPS can function as an anxiolytic without causing a subsequent sleep rebound.

Neuropeptide S Promotes Wakefulness Through Activation of the Posterior Hypothalamic Histaminergic and Orexinergic Neurons.

Neuropeptide S Counteracts Paradoxical Sleep Deprivation-Induced Anxiety-Like Behavior and Sleep Disturbances

Hypothalamic Neuronal Targets Activated by Neuropeptide S

Short Neuropeptide F is a Sleep-Promoting Inhibitory Modulator.

Neuropeptide S Facilitates Mice Olfactory Function Through Activation Of Cognate Receptor-Expressing Neurons In The Olfactory Cortex

The Ventromedial Hypothalamic Nucleus Plays an Important Role in Anxiolytic-Like Effect of Neuropeptide S

PROGRESS IN THE STUDIES OF FUNCTIONS AND STRUCTURE-ACTIVITY RELATIONSHIP OF NEUROPEPTIDE S

Neuropeptide S Reduces Propofol- or Ketamine-Induced Slow Wave States Through Activation of Cognate Receptors in the Rat

Neuropeptide S Attenuates the Alarm Pheromone-Evoked Defensive and Risk Assessment Behaviors Through Activation of Cognate Receptor-Expressing Neurons in the Posterior Medial Amygdala

Arousal Effect of Orexin A Depends on Activation of Hte Histmic System

Neuropeptide S overcomes short term memory deficit induced by sleep restriction by increasing prefrontal cortex activity

Neuropeptide S Produces Antinociceptive Effects at the Supraspinal Level in Mice

Neuropeptide S inhibits the acquisition and the expression of conditioned place preference to morphine in mice.

Neuropeptide S Induces Acute Anxiolysis by Phospholipase C-Dependent Signaling within the Medial Amygdala

Neuropeptide S Enhances Memory and Mitigates Memory Impairment Induced by MK801, Scopolamine or Aβ1–42 in Mice Novel Object and Object Location Recognition Tasks

Neuropeptide S- and Neuropeptide S receptor-expressing neuron populations in the human pons

Orexin increases the neuronal excitability of several brain areas associated with maintaining of arousal

Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues

Ca2+ in the Dorsal Raphe Nucleus Promotes Wakefulness Via Endogenous Sleep-Wake Regulating Pathway in the Rats

Neuropeptide S facilitates spatial memory and mitigates spatial memory impairment induced by N-methyl-D-aspartate receptor antagonist in mice.

Ca(2+) in the dorsal raphe nucleus promotes wakefulness via endogenous sleep-wake regulating pathway in the rats